CD40 and chronic myelogenous leukemia, BCR-ABL1 positive: In line with their lack of CAR expression, CML-DC were relatively resistant to transduction with Ad, but transduction efficiencies and GFP transgene expression levels could be significantly increased by retargeting Ad to CD40 as an alternate docking receptor (Figure 1C).